TREATMENT OF TYPE 2 DIABETES MELLITUS WITH GLP-1 RECEPTOR AGONISTS, CHRONIC KIDNEY DISEASE AND INFLUENCE ON CARDIOVASCULAR RISK. TJS. 2025;23(Supplement 1):6. doi:10.15547/tjs.2025.s.01.004